D-1299-2014 Class III Terminated

Recalled by Apotex Inc. — Toronto

FDA drug recall D-1299-2014 was initiated by Apotex Inc. on Mar 20, 2014 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications: Out of Specification for an impurity at the 18 month stability time point. The recall status is terminated (terminated Dec 23, 2014). Affected quantity: 11,422 bottles.

Recall details

Product Type
Drugs
Report Date
May 7, 2014
Initiation Date
Mar 20, 2014
Termination Date
Dec 23, 2014
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
11,422 bottles

Product description

Risperidone Oral Solution, 1 mg/mL, 30 mL bottle, Rx only, Manufactured by Apotex Inc., Toronto, Ontario, Canada M9L 1T9, Manufactured for Apotex Corp., Weston, FL 33326, NDC 60505-0380-1.

Reason for recall

Failed Impurities/Degradation Specifications: Out of Specification for an impurity at the 18 month stability time point.

Distribution pattern

Nationwide and Puerto Rico.

Code information

Lot #: KD4855, Exp 06/14

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1299-2014
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1299-2014. Report a data issue: hello@regdatalab.com.